Mok Oh

Pharmaceutical Sciences
Pharmaceutical Economics, Policy and Outcome
Astellas Pharma US
Senior Manager, Health Economics & Outcomes Research, Oncology
Dissertation Title: 
The Monetized Benefit of Knowing Genetic Information with Application to BRCA Mutation: Risk Reduction, Better Treatment, and Other Potential Values
Year Enrolled: 

Doctor of Pharmacy (2015), Sungkyunkwan University

Honors and Achievements: 

Poster Finalist, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 2019

New Venture Competition Grand Award, McGuire Center for Entrepreneurship, 2018

Fulbright Scholar Award, Bureau of Educational and Cultural Affairs of the U.S. Department, 2015-2017

Rho Chi Academic Honor Society in Pharmacy, member, 2017

William/Betty Mileson Fink Fellowship, University of Arizona, 2017

Academic Excellence Award, University of Arizona, 2017


​​​​​​Oh M, AlKhushym N, Fallatah S et al. The Association of BRCA1 and BRCA2 mutations on Prostate Cancer Risk, Frequency, and Mortality: A Meta-Analysis. The Prostate Journal, 2019;79(8):880-895. doi: 10.1002/pros.23795.

Oh M, McBride A, Yun S, et al. Response to Katona et al. Journal of National Cancer Institute, 2019;111(5):524-525. doi: 10.1093/jnci/djz013.

Oh M, McBride A, Yun S, et al. BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-Analysis. Journal of National Cancer Institute, 2018; 110(11):1178-1189. doi: 10.1093/jnci/djy148.

Almutairi A, Alkhatib N, Oh M, et al. Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs. Ipilimumab Monotherapy in Patients with Advanced Unresectable Melanoma. JAMA Dermatology, 2018; 155(1):22-28. doi: 10.1001/jamadermatol.2018.3958.

Bhattacharjee S, Oh M, Reiman M, et al. Prevalence, Patterns, and Predictors of Depression Treatment among Community-Dwelling Elderly Individuals with Dementia in the United States. American Journal of Geriatric Psychiatry. 2017:25(7):803-813. doi: 10.1016/j.jagp.2017.03.003.

Oh M, McBride A, Yun S, et al. Response to Yang, Shi, Wang et al. Journal of National Cancer Institute,

Career Type: